OPPM

Opus Point Partners Management Portfolio holdings

AUM $46.9M
This Quarter Return
+16.56%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$126M
AUM Growth
+$126M
Cap. Flow
+$6.07M
Cap. Flow %
4.81%
Top 10 Hldgs %
42.55%
Holding
65
New
10
Increased
31
Reduced
2
Closed
1

Top Buys

1
QGEN icon
Qiagen
QGEN
$3.24M
2
AXSM icon
Axsome Therapeutics
AXSM
$1.04M
3
HRTX icon
Heron Therapeutics
HRTX
$476K
4
PGNX
Progenics Pharmaceuticals Inc
PGNX
$411K
5
AKBA icon
Akebia Therapeutics
AKBA
$387K

Top Sells

1
QGENF
QIAGEN NV
QGENF
$3.13M
2
ALXN
Alexion Pharmaceuticals Inc
ALXN
$760K
3
LABU icon
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$266K

Sector Composition

1 Healthcare 79.39%
2 Real Estate 0.68%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ALXN
26
DELISTED
Alexion Pharmaceuticals Inc
ALXN
$2.27M 1.68%
18,701
-6,272
-25% -$760K
CLVS
27
DELISTED
Clovis Oncology, Inc.
CLVS
$1.91M 1.42%
30,000
– –
PRTK
28
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.54M 1.14%
80,000
– –
TSRO
29
DELISTED
TESARO, Inc.
TSRO
$1.54M 1.14%
10,000
– –
MDCO
30
DELISTED
Medicines Co
MDCO
$1.37M 1.02%
28,000
– –
ADMS
31
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$1.05M 0.78%
60,000
– –
AXSM icon
32
Axsome Therapeutics
AXSM
$6.05B
$1.04M 0.77%
+267,000
New +$1.04M
PTLA
33
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$980K 0.73%
25,000
– –
SNR
34
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$854K 0.63%
83,700
– –
RARE icon
35
Ultragenyx Pharmaceutical
RARE
$2.89B
$827K 0.61%
12,201
+1,337
+12% +$90.6K
CFRX
36
DELISTED
ContraFect Corporation
CFRX
$540K 0.4%
300,000
– –
HRTX icon
37
Heron Therapeutics
HRTX
$207M
$476K 0.35%
+31,748
New +$476K
KITE
38
DELISTED
Kite Pharma, Inc.
KITE
$466K 0.35%
5,931
+564
+11% +$44.3K
SCTL
39
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$441K 0.33%
50,463
+10,463
+26% +$91.4K
LABU icon
40
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$647M
$416K 0.31%
8,723
-5,577
-39% -$266K
GRFS icon
41
Grifois
GRFS
$6.78B
$414K 0.31%
21,932
+5,319
+32% +$100K
PGNX
42
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$411K 0.31%
+43,565
New +$411K
IQV icon
43
IQVIA
IQV
$32.4B
$405K 0.3%
5,027
+1,609
+47% +$130K
JUNO
44
DELISTED
Juno Therapeutics, Inc.
JUNO
$400K 0.3%
18,030
+6,552
+57% +$145K
CRL icon
45
Charles River Laboratories
CRL
$8.04B
$399K 0.3%
4,441
+1,138
+34% +$102K
NBIX icon
46
Neurocrine Biosciences
NBIX
$13.8B
$398K 0.3%
9,184
+3,047
+50% +$132K
IOVA icon
47
Iovance Biotherapeutics
IOVA
$807M
$396K 0.29%
53,157
+14,210
+36% +$106K
LGND icon
48
Ligand Pharmaceuticals
LGND
$3.15B
$394K 0.29%
3,719
+1,130
+44% +$120K
MYGN icon
49
Myriad Genetics
MYGN
$593M
$393K 0.29%
20,484
+6,577
+47% +$126K
GILD icon
50
Gilead Sciences
GILD
$140B
$390K 0.29%
5,737
+2,329
+68% +$158K
1
2
3